Product NDC: | 47781-368 |
Proprietary Name: | Nifedipine |
Non Proprietary Name: | nifedipine |
Active Ingredient(s): | 30 mg/1 & nbsp; nifedipine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 47781-368 |
Labeler Name: | Alvogen, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020198 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 19930421 |
Package NDC: | 47781-368-01 |
Package Description: | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (47781-368-01) |
NDC Code | 47781-368-01 |
Proprietary Name | Nifedipine |
Package Description | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (47781-368-01) |
Product NDC | 47781-368 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | nifedipine |
Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 19930421 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Alvogen, Inc. |
Substance Name | NIFEDIPINE |
Strength Number | 30 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |